Skip to main content

Incyte Customer B (change on a year)

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

Customer B (change on a year) at Incyte came to 7% for the quarter to 30 Jun 2026, down 2.0 points from a year earlier.

As Incyte reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 28 Jul 2026.

By quarter

10%Sep 202211%Mar 20239%Jun 202310%Sep 202311%Mar 202410%Jun 202410%Sep 202410%Mar 20259%Jun 20258%Sep 20258%Mar 20267%Jun 2026
Incyte Customer B (change on a year), every reported period
Period endingCustomer B (change on a year)Change on a yearFiled
30 Jun 20267%down 2.0 points28 Jul 2026
31 Mar 20268%down 2.0 points28 Apr 2026
30 Sep 20258%down 2.0 points28 Oct 2025
30 Jun 20259%down 1.0 points29 Jul 2025
31 Mar 202510%down 1.0 points29 Apr 2025
30 Sep 202410%unchanged29 Oct 2024
30 Jun 202410%up 1.0 points30 Jul 2024
31 Mar 202411%unchanged30 Apr 2024
30 Sep 202310%unchanged31 Oct 2023
30 Jun 20239%down 3.0 points1 Aug 2023
31 Mar 202311%down 1.0 points2 May 2023
30 Sep 202210%down 1.0 points1 Nov 2022
30 Jun 202212%down 1.0 points2 Aug 2022
31 Mar 202212%down 1.0 points3 May 2022
30 Sep 202111%down 2.0 points2 Nov 2021
30 Jun 202113%down 1.0 points3 Aug 2021
31 Mar 202113%unchanged4 May 2021
30 Sep 202013%down 1.0 points5 Nov 2020
30 Jun 202014%up 1.0 points4 Aug 2020
31 Mar 202013%—5 May 2020
30 Sep 201914%up 2.0 points29 Oct 2019
30 Jun 201913%down 2.0 points30 Jul 2019
30 Sep 201812%down 4.0 points30 Oct 2018
30 Jun 201815%down 1.0 points31 Jul 2018
30 Sep 201716%—31 Oct 2017
30 Jun 201716%—1 Aug 2017

Definition

Customer B (change on a year) as Incyte defines and reports it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Incyte: Customer A (change on a year) · Customer C (change on a year) · JAKAFI revenue · OPZELURA revenue · Product royalty revenues · JAKAVI revenue · NIKTIMVO revenue · ZYNYZ revenue · MINJUVI/MONJUVI revenue · Milestone and contract revenues · OLUMIANT revenue · ICLUSIG revenue · PEMAZYRE revenue · TABRECTA revenue · United States revenue · Europe revenue · financial statements

Every KPI and segment of INCY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.